Exploring your options for Acute Leukemia in India? Ginger Healthcare brings together a carefully chosen panel of reputed hematologists, practising at world-class hospitals accredited by JCI and NABH. Request a free opinion and a cost estimate from any doctor on the list, and our team will guide you through every step of your journey.
Here are the most reputed doctors in India for Acute Leukemia Treatment. Each specialist is carefully vetted for their expertise, experience, and patient outcomes.
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Here are the most reputed hospitals in India for Acute Leukemia Treatment. These hospitals are known for advanced infrastructure, international accreditations, and high success rates.
Acute leukemia is a rapidly progressing cancer of the blood and bone marrow in which abnormal immature white blood cells — called blasts — multiply uncontrollably and crowd out healthy blood cell production. It occurs in two main forms: Acute Myeloid Leukemia (AML), more common in adults, and Acute Lymphoblastic Leukemia (ALL), which is the most frequent cancer in children. Because the disease advances quickly, treatment almost always begins within days of diagnosis. The treatment pathway involves multiple phases — induction chemotherapy to achieve remission, consolidation therapy to eliminate residual disease, and in higher-risk patients, a stem cell (bone marrow) transplant to offer the best chance of long-term cure. Outcomes have improved substantially in recent decades, and many patients, especially children with ALL and adults with favourable genetic subtypes, achieve durable remission or cure.
Intensive inpatient chemotherapy — typically the '7+3' regimen — given over 4–5 weeks to bring Acute Myeloid Leukemia into remission by eliminating blast cells from the bone marrow.
Estimated cost: ~$1,000 – $1,500
Typical tests: Complete blood count (CBC) with differential, Bone marrow aspiration and biopsy, Immunophenotyping (flow cytometry), Cytogenetics (karyotype), Molecular mutation panel (FLT3, NPM1, IDH1/2), LFT, KFT, serum electrolytes, uric acid, 2D Echocardiogram (cardiac fitness for anthracyclines), Infection screening — Hepatitis B, Hepatitis C, HIV. Done in India before admission.
Estimated cost in India: $10,000 – $12,000
Treatment duration in India: ~5 weeks (~30 hospital visit days across the full span)
Multi-drug induction chemotherapy over 4–6 weeks for Acute Lymphoblastic Leukemia, combining cytotoxic agents, steroids, and CNS-directed intrathecal chemotherapy to achieve remission.
Estimated cost: ~$1,000 – $1,500
Typical tests: Complete blood count (CBC) with differential, Bone marrow aspiration and biopsy, Immunophenotyping (flow cytometry) — B-cell vs T-cell lineage, Cytogenetics (karyotype) including Philadelphia chromosome (BCR-ABL1) testing, Lumbar puncture with CSF analysis (CNS involvement), LFT, KFT, serum electrolytes, uric acid, 2D Echocardiogram (cardiac fitness), Infection screening — Hepatitis B, Hepatitis C, HIV. Done in India before admission.
Estimated cost in India: $5,500 – $7,000
Treatment duration in India: ~6 weeks (~35 hospital visit days across the full span)
Targeted combination therapy using ATRA (all-trans retinoic acid) and arsenic trioxide — the standard regimen for the APL subtype of AML, given over 6–8 weeks with high remission rates.
Estimated cost: ~$1,000 – $1,500
Typical tests: Complete blood count (CBC) with differential, Bone marrow aspiration and biopsy, PML-RARA fusion gene testing (FISH or RT-PCR), Coagulation profile (PT, APTT, fibrinogen) — critical in APL due to DIC risk, LFT, KFT, serum electrolytes, ECG and QTc interval assessment (arsenic trioxide monitoring), 2D Echocardiogram, Infection screening — Hepatitis B, Hepatitis C, HIV. Done in India before admission.
Estimated cost in India: $13,000 – $19,000
Treatment duration in India: ~7 weeks (~42 hospital visit days across the full span)
Replacement of the diseased bone marrow with donor stem cells after high-dose conditioning chemotherapy — the treatment offering the best chance of long-term cure in high-risk or relapsed acute leukemia.
Estimated cost in India: $20,000 – $45,000
For more details, visit: Bone Marrow Transplant (BMT) →
Intensive rescue chemotherapy used when leukemia returns after remission or does not respond to initial induction — aimed at achieving a second remission, often as a bridge to stem cell transplant.
Estimated cost: ~$1,000 – $1,500
Typical tests: Complete blood count (CBC) with differential, Repeat bone marrow aspiration and biopsy (to confirm relapse/refractory status), Repeat immunophenotyping and molecular mutation panel, MRD (measurable residual disease) testing, LFT, KFT, serum electrolytes, 2D Echocardiogram (cardiac fitness for further intensive therapy), HLA typing (if transplant is being planned as next step), Infection screening — Hepatitis B, Hepatitis C, HIV. Done in India before admission.
Estimated cost in India: $18,000 – $25,000
Treatment duration in India: ~3 months (~60 hospital visit days across the full span)
From your first enquiry to recovery back home — we manage every detail so you can focus on getting better.
Join 5,000+ patients from 40+ countries who chose world-class care at a fraction of the cost.
